Henry Schein, Inc. (NASDAQ:HSIC) Shares Sold by Allspring Global Investments Holdings LLC

Allspring Global Investments Holdings LLC lowered its stake in Henry Schein, Inc. (NASDAQ:HSIC) by 3.2% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 5,670 shares of the company’s stock after selling 186 shares during the quarter. Allspring Global Investments Holdings LLC’s holdings in Henry Schein were worth $413,000 at the end of the most recent quarter.

Several other institutional investors have also bought and sold shares of HSIC. Summit Securities Group LLC acquired a new stake in Henry Schein during the 2nd quarter worth about $31,000. Beach Investment Counsel Inc. PA bought a new stake in Henry Schein during the second quarter worth approximately $37,000. Blue Trust Inc. boosted its position in shares of Henry Schein by 104.2% in the second quarter. Blue Trust Inc. now owns 931 shares of the company’s stock valued at $60,000 after acquiring an additional 475 shares during the period. Livforsakringsbolaget Skandia Omsesidigt boosted its position in shares of Henry Schein by 282.1% in the third quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 1,490 shares of the company’s stock valued at $109,000 after acquiring an additional 1,100 shares during the period. Finally, Mather Group LLC. raised its stake in shares of Henry Schein by 16.8% in the second quarter. Mather Group LLC. now owns 1,502 shares of the company’s stock valued at $96,000 after purchasing an additional 216 shares in the last quarter. Institutional investors and hedge funds own 96.62% of the company’s stock.

Henry Schein Trading Up 0.2 %

Shares of Henry Schein stock opened at $70.37 on Friday. The company has a quick ratio of 0.90, a current ratio of 1.55 and a debt-to-equity ratio of 0.46. The stock has a market cap of $8.92 billion, a P/E ratio of 26.06, a P/E/G ratio of 2.02 and a beta of 0.87. Henry Schein, Inc. has a 12-month low of $60.01 and a 12-month high of $82.63. The business’s 50 day moving average is $70.63 and its 200-day moving average is $69.79.

Henry Schein (NASDAQ:HSIC) last released its earnings results on Tuesday, August 6th. The company reported $1.23 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.22 by $0.01. The company had revenue of $3.10 billion for the quarter, compared to analyst estimates of $3.27 billion. Henry Schein had a return on equity of 13.19% and a net margin of 2.82%. Henry Schein’s quarterly revenue was up .0% on a year-over-year basis. During the same period in the prior year, the firm posted $1.31 EPS. Equities research analysts predict that Henry Schein, Inc. will post 4.74 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several brokerages recently commented on HSIC. Robert W. Baird reduced their target price on Henry Schein from $92.00 to $82.00 and set an “outperform” rating for the company in a research report on Wednesday, August 7th. Evercore ISI lifted their price objective on Henry Schein from $70.00 to $74.00 and gave the stock an “in-line” rating in a research report on Tuesday, October 8th. StockNews.com lowered Henry Schein from a “hold” rating to a “sell” rating in a research report on Wednesday. JPMorgan Chase & Co. decreased their target price on Henry Schein from $88.00 to $80.00 and set an “overweight” rating for the company in a research report on Monday, August 12th. Finally, Barrington Research reiterated an “outperform” rating and issued a $82.00 price objective on shares of Henry Schein in a research report on Friday, September 20th. Two equities research analysts have rated the stock with a sell rating, five have assigned a hold rating, five have issued a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Hold” and an average target price of $77.50.

Insider Buying and Selling

In other Henry Schein news, SVP Lorelei Mcglynn sold 21,035 shares of the stock in a transaction dated Friday, September 6th. The stock was sold at an average price of $69.30, for a total value of $1,457,725.50. Following the completion of the transaction, the senior vice president now directly owns 71,833 shares in the company, valued at approximately $4,978,026.90. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 1.14% of the stock is owned by corporate insiders.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.